New York: A prominent Indian-American doctor and his wife have agreed to pay USD 1.2 million to settle allegations of prescribing unapproved drugs in the US.
Anindya Sen, 68, owns two cancer centres in Greeneville and Johnson City in Tennessee. His wife Patricia Posey Sen, 69, managed his medical practice from 2009 through 2012.
The couple allegedly profited by administering the cheaper unapproved drugs, the Department of Justice said.
They will pay USD 1.2 million to resolve state and federal False Claims Act allegations that their medical practice billed Medicare and Tennessee Medicaid for anti-cancer and infusion drugs that were produced for sale in foreign countries and not approved by the Food and Drug Administration (FDA) for marketing in the US, it said.
"Billing for foreign drugs that are not approved by the FDA undermines federal healthcare programmes and could potentially risk patient safety," said Acting Assistant Attorney General Chad Readler of the Justice Department's Civil Division.
The government alleged that the unapproved drugs that the Sens provided to patients and billed to Medicare were not reimbursable under those programmes.
It is further alleged that the Sens purchased unapproved drugs because they were less expensive than the drugs approved by FDA for marketing in the US.
Claims settled by this agreement are allegations only and there has been no determination of liability, the Justice Department added.
Anindya Sen, 68, owns two cancer centres in Greeneville and Johnson City in Tennessee. His wife Patricia Posey Sen, 69, managed his medical practice from 2009 through 2012.
The couple allegedly profited by administering the cheaper unapproved drugs, the Department of Justice said.
"Billing for foreign drugs that are not approved by the FDA undermines federal healthcare programmes and could potentially risk patient safety," said Acting Assistant Attorney General Chad Readler of the Justice Department's Civil Division.
Advertisement
It is further alleged that the Sens purchased unapproved drugs because they were less expensive than the drugs approved by FDA for marketing in the US.
Advertisement
COMMENTS
Advertisement
Elon Musk's Neuralink Gets Go Ahead For Brain Chip Implant In 2nd Patient: Report Maharashtra Revokes Licence Of McDonald's Outlet After Action Over Cheese US Woman Enters MRI Machine With Loaded Gun, Gets Shot In Buttock Area 2 French Rafale Jets Collide Mid-Air, Instructor, Pilot Missing Ayatollah Khamenei Warns Of "Divine Wrath" If Iran Backs Down Against Israel 9 Arrested For Violence At Kolkata Hospital Where Doctor Was Raped-Murdered Water On Mars: Uncovering All The Locations Water Was Found On Red Planet Huge Participation At Independence Day Celebrations By Army's Spear Corps Akasa Air Flight Makes Emergency Landing In Bhopal For Sick Passenger Track Latest News Live on NDTV.com and get news updates from India and around the world.